Cargando…
Anti-tuberculosis drug development via targeting the cell envelope of Mycobacterium tuberculosis
Mycobacterium tuberculosis possesses a dynamic cell envelope, which consists of a peptidoglycan layer, a mycolic acid layer, and an arabinogalactan polysaccharide. This envelope possesses a highly complex and unique structure representing a barrier that protects and assists the growth of M. tubercul...
Autores principales: | Xu, Xinyue, Dong, Baoyu, Peng, Lijun, Gao, Chao, He, Zhiqun, Wang, Chuan, Zeng, Jumei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810820/ https://www.ncbi.nlm.nih.gov/pubmed/36620019 http://dx.doi.org/10.3389/fmicb.2022.1056608 |
Ejemplares similares
-
Improved Conventional and New Approaches in the Diagnosis of Tuberculosis
por: Dong, Baoyu, et al.
Publicado: (2022) -
Drug-resistant strains of Mycobacterium tuberculosis: cell envelope profiles and interactions with the host
por: Schami, Alyssa, et al.
Publicado: (2023) -
Effect of common and experimental anti-tuberculosis treatments on Mycobacterium tuberculosis growing as biofilms
por: Dalton, James P., et al.
Publicado: (2016) -
Targeting the Mycobacterium tuberculosis Stringent Response as a Strategy for Shortening Tuberculosis Treatment
por: Danchik, Carina, et al.
Publicado: (2021) -
The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis
por: Evans, Joanna C., et al.
Publicado: (2015)